Showing 581-590 of 856 results for "".
- FDA Issues Alert for Counterfeit Botox Across Multiple U.S. Stateshttps://modernaesthetics.com/news/fda-issues-alert-for-counterfeit-botox-across-multiple-us-states/2473560/The U.S. Food and Drug Administration (FDA) has issued an alert regarding counterfeit botulinum toxin that has been detected in several states. The agency issued a statement on April 16 noting that it is aware of the issue and is working with the Centers for Disease Control (CDC),
- Botulism-Like Symptoms Linked to Suspected Fake Cosmetic Injections in Illinoishttps://modernaesthetics.com/news/botulism-like-symptoms-linked-to-suspected-fake-cosmetic-injections-in-illinois/2473557/The Illinois Department of Public Health (IDPH) has issued a warning to healthcare facilities, particularly hospital ERs, urging heightened vigilance for patients exhibiting symptoms resembling botulism. The advisory follows the identification of a clus
- Allergan Aesthetics Launches Program to Elevate the Conversation Around Ethics in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-launches-program-to-elevate-the-conversation-around-ethics-in-aesthetics/2473556/Allergan Aesthetics announced the launch of 'Moving the Needle on Ethics,' a collaboration with medical aesthetics experts from around the globe aimed at elevating discussions on ethics in aesthetics. The collection of interviews is designed to highlight the
- FDA Approves Juvederm Voluma XC for Temple Hollowinghttps://modernaesthetics.com/news/fda-approves-juvederm-voluma-xc-for-temple-hollowing/2473553/Allergan Aesthetics has received FDA approval of Juvederm Voluma XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.[1] The injection is the first and only hyaluronic acid (HA) dermal filler to receive FDA approval
- Kenvue to Showcase 22 New Sets of Clinical Data at AADhttps://modernaesthetics.com/news/kenvue-to-showcase-22-new-sets-of-clinical-data-at-aad/2473552/Kenvue announced it will share 22 data sets detailing new Kenvue skin science research at the American Academy of Dermatology (AAD) Association annual meeting, March 8-12, in San Diego. Evidence will be presented on the clinical effectiveness of Neutrogena and Aveeno
- Trufacial Touts Survey Showing High Satisfaction with Facial Rejuvenation Systemhttps://modernaesthetics.com/news/trufacial-survery-results/2473550/A market survey of 100 female consumers revealed that 100% of participants found the skin-perfecting TrufacialTM hand-held device not only met their skincare needs, but also exceeded expectations after only
- Cutera Launches AviClear for the Treatment of Acne in UK, Europe and Australiahttps://modernaesthetics.com/news/cutera-launches-aviclear-for-the-treatment-of-acne-in-uk-europe-and-australia/2473548/Cutera announced the international limited commercial release of AviClear, which the company describes as the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear is now commercially available, on a limited basis, in the UK, Europe, a
- Beauty and Self-Care Brands Announce Rennaï Spotshttps://modernaesthetics.com/news/beauty-and-self-care-brands-announce-rennai-spots/2473546/Rennaï, a new beauty and self-care retail concept in Montreal, announced that luxury global brand Hermes will be joining world-renowned professional-grade skin care brand Dermalogica at its flagship location at Royalmount. The combination of coveted luxury brands, ma
- Tracking Trends in Breast Implant Surgery Techniques From 2005 to 2020https://modernaesthetics.com/news/tracking-trends-in-breast-implant-surgery-techniques-from-2005-to-2020/2473538/Breast implant placement with inframammary incisions increased from 68% to 80%, while use of peri-areolar incisions decreased from 24% to 14% between 2005 and 2020, according to a study in the December 2023 issue of Plastic and Reconstruct
- Exosome X Mitochondrial Technology: Elevai Labs Enters Into Licensing Agreement With Yuva Bioscienceshttps://modernaesthetics.com/news/exosome-x-mitochondrial-technologies-elevai-labs-enters-into-licensing-agreement-with-yuva-biosciences/2473536/Elevai Labs, Inc. signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx (Precision Regenerative Exosome Technology) in topical skincare. The potential collab could com